INGN Inogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INGN

Price (delayed)

$6.59

Market cap

$153.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.42

Enterprise value

$50.15M

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
The debt has declined by 6% year-on-year and by 3.7% since the previous quarter
The gross margin has grown by 2.8% from the previous quarter
Inogen's net income has increased by 23% from the previous quarter but it has decreased by 22% YoY
Inogen's EPS has increased by 23% from the previous quarter but it has decreased by 20% YoY
The quick ratio has contracted by 38% YoY and by 24% from the previous quarter
The equity has declined by 31% year-on-year and by 11% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inogen.net
Peers: MASI ELMD GTLS RMD

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
23.33M
Market cap
$153.72M
Enterprise value
$50.15M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.75
Price to sales (P/S)
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.16
Earnings
Revenue
$315.66M
EBIT
-$102.34M
EBITDA
-$84.19M
Free cash flow
-$30.25M
Per share
EPS
-$4.42
Free cash flow per share
-$1.31
Book value per share
$8.79
Revenue per share
$13.62
TBVPS
$12.15
Balance sheet
Total assets
$326.19M
Total liabilities
$121.38M
Debt
$21.92M
Equity
$204.81M
Working capital
$134.57M
Liquidity
Debt to equity
0.11
Current ratio
2.86
Quick ratio
2.35
Net debt/EBITDA
1.23
Margins
EBITDA margin
-26.7%
Gross margin
40.1%
Net margin
-32.5%
Operating margin
-34.7%
Efficiency
Return on assets
-28.7%
Return on equity
-41.3%
Return on invested capital
-77.6%
Return on capital employed
-40.3%
Return on sales
-32.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
-6.52%
1 week
-7.05%
1 month
-12.37%
1 year
-50.11%
YTD
20.04%
QTD
-18.34%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$315.66M
Gross profit
$126.7M
Operating income
-$109.39M
Net income
-$102.45M
Gross margin
40.1%
Net margin
-32.5%
The operating margin has plunged by 54% YoY but it has grown by 18% from the previous quarter
The net margin has declined by 46% year-on-year but it has grown by 20% since the previous quarter
INGN's operating income is down by 28% year-on-year but it is up by 21% since the previous quarter
Inogen's net income has increased by 23% from the previous quarter but it has decreased by 22% YoY

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.75
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.16
Inogen's EPS has increased by 23% from the previous quarter but it has decreased by 20% YoY
INGN's P/B is 65% below its 5-year quarterly average of 2.3
The equity has declined by 31% year-on-year and by 11% since the previous quarter
The stock's price to sales (P/S) is 77% less than its 5-year quarterly average of 2.3 and 13% less than its last 4 quarters average of 0.6
The revenue has declined by 16% year-on-year and by 3.7% since the previous quarter

Efficiency

How efficient is Inogen business performance
Inogen's return on equity has shrunk by 68% YoY but it has increased by 16% QoQ
Inogen's ROA has plunged by 56% YoY but it has increased by 18% from the previous quarter
Inogen's ROS has decreased by 47% YoY but it has increased by 19% from the previous quarter
INGN's ROIC is down by 25% YoY but it is up by 17% from the previous quarter

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is 169% greater than its total liabilities
The company's current ratio fell by 39% YoY and by 23% QoQ
The quick ratio has contracted by 38% YoY and by 24% from the previous quarter
The debt is 89% smaller than the equity
The debt to equity has increased by 38% YoY and by 10% from the previous quarter
The equity has declined by 31% year-on-year and by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.